Nanosphere based oral insulin delivery

1993, The effect of intensive treatment on the development and progression of long-term complications in insulin-dependent diabetes mellitus, New Engl. J. Med., 8329, 977

Mesiha, 1994, Enhanced oral absorption of insulin from desolvated fatty acid–sodium glycocholate emulsions, Int. J. Pharm., 213, 10.1016/0378-5173(94)90343-3

Fasano, 1997, Modulation of intestinal tight junctions by zona occludens toxin permits enteral administration of insulin and other macromolecules in an animal model, J. Clin. Invest., 99, 1158, 10.1172/JCI119271

Yamamoto, 1994, Effects of various protease inhibitors on the intestinal absorption and degradation of insulin in rats, Pharm. Res., 11, 1496, 10.1023/A:1018968611962

Morishita, 1993, Site-dependent effect of aprotinin, sodium caprate, Na2 EDTA and sodium glycocholate on the intestinal absorption of insulin, Biol. Pharm. Bull, 68, 10.1248/bpb.16.68

Touitou, 1986, Targeted enteral delivery of insulin to rats, Int. J. Pharmaceut., 95, 10.1016/0378-5173(86)90069-4

Morishita, 1993, Enteral insulin delivery by microspheres in three different formulations using Eudragit l100 and S100, Int. J. Pharm., 29, 10.1016/0378-5173(93)90418-F

Gwinup, 1991, Insulin and C-peptide levels following oral administration of insulin in intestinal-enzyme protected capsules, Gen. Pharmac., 22, 243, 10.1016/0306-3623(91)90440-H

Damge, 1986, Advantage of a new colloidal drug delivery system in the insulin treatment of Streptozotcin-induced diabetic rats, Diabetologica, 29, 531A

Couvreur, 1980, Oral and parenteral administration of insulin associated to hydrolyzable nanoparticles, Acta. Pharm. Technol., 26, 220

Mathiowitz, 1997, Biologically erodable microspheres as potential oral drug delivery systems, Nature, 386, 410, 10.1038/386410a0

Domb, 1987, Polyanhydrides. I. Preparation of high molecular weight polyanhydrides, J. Poly. Sci., 3373, 10.1002/pola.1987.080251217

Chickering, 1996, Poly(fumaric-co-sebacic) microspheres as oral drug delivery systems, Biotechnol. Bioeng., 52, 96, 10.1002/(SICI)1097-0290(19961005)52:1<96::AID-BIT9>3.0.CO;2-U

Tutwiler, 1978, A pharmacologic profile of McN-3495 [N-(1-methyl-2-pyrrolodinylidene)-N′-phenyl-1-pyrrolidinecarboximidamide], a new, orally effective hypoglycemic agent, Diabetes, 27, 856, 10.2337/diabetes.27.8.856

Santos, 1997, Correlation of two bioadhesion assays, 24, 261

Santos, 1999, Poly(fumaric-co-sebacic anhydride): a degradation study as evaluated by FTIR, DSC, GPC and X-Ray diffraction, J. Control. Rel., 60, 11, 10.1016/S0168-3659(99)00016-4

G.P. Carino, J.S. Jacob, C. James Chen, Camilla A. Santos, Benjamin A. Hertzog, Edith Mathiowitz, Bioadhesive, Bioerodible Polymers for Increased Intestinal Uptake, in: Edith Mathiowitz, Donald E. Chickering III, Claus-Michael Lehr (Eds.), James Swarbrick (Series Ed.), Bioadhesive Drug Delivery Systems: Fundamentals, Novel Approaches and Development, Drugs and the Pharmaceutical Sciences Series, Marcel Dekker, Inc., New York, 1999, pp. 459–475.

Ermak, 1995, Uptake and transport of copolymer biodegradable microspheres by Rabbit Peyer’s patch M cells, Cell Tissue Res., 279, 433, 10.1007/BF00318501

Jani, 1989, The uptake and translocation of latex nanospheres and microspheres after oral administer to rats, J. Pharm. Pharmacol., 41, 809, 10.1111/j.2042-7158.1989.tb06377.x